The safety and efficacy of ten percent pentastarch as a cardiopulmonary bypass priming solution
- 1 August 1992
- journal article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 104 (2) , 284-296
- https://doi.org/10.1016/s0022-5223(19)34780-4
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Low molecular weight hydroxyethyl starch 6% compared to albumin 4% during intentional hemodilutionIntensive Care Medicine, 1991
- Effects of pentastarch and albumin infusion on cardiorespiratory function and coagulation in patients with severe sepsis and systemic hypoperfusionCritical Care Medicine, 1989
- Hemodynamic and Oxygen Transport Effects of Pentastarch in Burn ResuscitationAnnals of Surgery, 1989
- Comparison of hydroxyethyl starch and lactated Ringerʼs solution on hemodynamics and oxygen transport of critically ill patients in prospective crossover studiesCritical Care Medicine, 1989
- Clinical pharmacokinetics and pharmacodynamics of colloidal plasma volume expandersJournal of Cardiothoracic Anesthesia, 1988
- Volume replacement and coagulation: A comparative reviewJournal of Cardiothoracic Anesthesia, 1988
- Plasma volume expansion in cardiovascular surgery: Practical realities, theoretical concernsJournal of Cardiothoracic Anesthesia, 1988
- Microvascular permeability after cardiopulmonary bypassThe Journal of Thoracic and Cardiovascular Surgery, 1987
- A multicenter trial to document the efficacy and safety of a rapidly excreted analog of hydroxyethyl starch for leukapheresis with a note on steroid stimulation of granulocyte donorsTransfusion, 1986
- Panel II: Dosage and scheduling regimens for erythrocyte‐sedimenting macromoleculesJournal of Clinical Apheresis, 1983